Poliomyelitis vaccine in the dragee candy Market

Global Poliomyelitis vaccine in the dragee candy Market Size, Share & Trends Analysis Report by Type (Oral Poliovirus Vaccine (OPV), Inactivated polio vaccine (IPV)) by Application (Hospital, Clinics, Medical Centers, others) and Forecast (2020-2026)

Published: Oct 2021 | Report Code: OMR2024279 | Category : Pharmaceuticals | Delivery Format: /

Global Poliomyelitis vaccine in the dragee candy market is estimated to grow at a significant CAGR during the forecast period. Poliomyelitis Vaccine is a vaccine that is used to prevent the disease poliomyelitis.  It is used as both.  an inactivated poliovirus that's injected and a weakened poliovirus that's taken orally (OPV). Oral polio vaccines cause around three cases of vaccine-associated paralytic poliomyelitis for every million doses administered. All children should be completely vaccinated against polio, according to the World Health Organization. Dragee candy is a colorful coated candy with a hard outer shell and a softer interior, that is commonly used for decorating as well as eating.

Poliomyelitis is an acute communicable disease caused by the poliovirus, a human enterovirus. Poliovirus is spread via oral contact, saliva, or feces from an infected individual. According to a March 2018 study from the World Health Organization (WHO), wild-type poliovirus infections have dropped by almost 99 percent since 1988. Even though, most countries like the United States and India, are free from polio but the endemic transmission of the virus continues in Afghanistan, Nigeria, and Pakistan, due to difficulties in adopting strategic approaches such as appropriate vaccination.

The poliomycetes vaccine market in dragee candy is anticipated to expand due to an increase in the number of mergers and acquisitions of major companies in the poliovirus vaccine market. For instance, in April 2017, Serum Institute of India Pvt. Ltd. acquired US USD 82.08 million for Nanotherapeutics, a Czech company. Serum Institute was able to increase its injectable polio vaccine manufacturing capacity to 200 million doses as a result of this acquisition, making it the world's largest polio vaccine manufacturer. Increasing innovation and development in Poliomycetes Vaccine in Dragee Candy across the globe is driving the market growth of Poliomycetes Vaccine in Dragee Candy.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment covered 

o By Type

o By Application

  • Region covered

o Global

  • Competitive Landscape- Sanofi., Gansu Conbest Biotech Company ltd., Shenzhen Mellow Hope Pharm Industrial., United Pharma Industries.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Market Segmentation

Global Poliomyelitis vaccine in the dragee candy market is segmented by Type

o Oral Poliovirus Vaccine (OPV)

o Inactivated polio vaccine (IPV)

Global Poliomyelitis vaccine in the dragee candy market is segmented by Application 

o Hospital 

o Clinics

o Medical Centers 

o Others

Global Poliomyelitis vaccine in the dragee candy market is segmented by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

REQUEST FOR TABLE OF CONTENT